Genmab
GMAB
GMAB
246 hedge funds and large institutions have $1.94B invested in Genmab in 2025 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 98 increasing their positions, 63 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% more capital invested
Capital invested by funds: $1.33B → $1.94B (+$618M)
14% more funds holding
Funds holding: 216 → 246 (+30)
0.3% less ownership
Funds ownership: 9.94% → 9.63% (-0.3%)
Holders
246
Holding in Top 10
3
Calls
$2.43M
Puts
$558K
Top Buyers
| 1 | +$117M | |
| 2 | +$96.8M | |
| 3 | +$53M | |
| 4 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
+$17.2M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$14.8M |
Top Sellers
| 1 | -$108M | |
| 2 | -$42.1M | |
| 3 | -$31.4M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$25.1M |
| 5 |
JP Morgan Chase
New York
|
-$25M |
